Nalaganje...
Hepatocellular carcinoma (HCC): beyond sorafenib—chemotherapy
Hepatocellular carcinoma (HCC) is the most common primary liver cancer with poor prognosis. The incidence of HCC and HCC-related deaths have increased over the last several decades. However, the treatment options for advanced HCC are very limited. Sorafenib remains the only drug approved for systemi...
Shranjeno v:
| izdano v: | J Gastrointest Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AME Publishing Company
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5401857/ https://ncbi.nlm.nih.gov/pubmed/28480065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.09.07 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|